EFFICACY AND SAFETY OF LENVATINIB COMBINED WITH DIFFERENT ANTI-PD-1 ANTIBODY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A REAL WORLD EVIDENCE BASED RETROSPECTIVE STUDY

被引：0
|
作者：
Chen, Bowen [1 ]
Zhang, Linzhi [2 ,3 ]
Cheng, Jiamin, Sr. [2 ]
Yan, Tao [2 ]
Lu, Yinying [1 ]
机构：
[1] Peking Univ, Clin Med Sch 302, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China
[3] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1045
引用
收藏
页码：637A / 638A
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of anti-PD-1 monotherapy versus anti-PD-1 antibodies plus lenvatinib in patients with advanced hepatocellular carcinoma: a real-world experience
    Liu, Qingyan
    Li, Rong
    Li, Lingling
    Wang, Gaokun
    Ji, Shiyu
    Zheng, Xuan
    Jia, Xiaodong
    Tao, Haitao
    Hu, Yi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [2] A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer
    Bangyou Zuo
    Xiaobo Yang
    Xu Yang
    Jin Bian
    Junyu Long
    Dongxu Wang
    Cong Ning
    Yanyu Wang
    Ziyu Xun
    Yunchao Wang
    Xin Lu
    Yilei Mao
    Xinting Sang
    Haitao Zhao
    Cancer Immunology, Immunotherapy, 2022, 71 : 1889 - 1896
  • [3] A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer
    Zuo, Bangyou
    Yang, Xiaobo
    Yang, Xu
    Bian, Jin
    Long, Junyu
    Wang, Dongxu
    Ning, Cong
    Wang, Yanyu
    Xun, Ziyu
    Wang, Yunchao
    Lu, Xin
    Mao, Yilei
    Sang, Xinting
    Zhao, Haitao
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (08) : 1889 - 1896
  • [4] Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients
    Zou, Jixue
    Huang, Peixin
    Ge, Ningling
    Xu, Xin
    Wang, Yanhong
    Zhang, Lan
    Chen, Yi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 1898 - 1906
  • [5] Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
    Shimozato, Naotaka
    Namisaki, Tadashi
    Okano, Akihiro
    Ohana, Masaya
    Kinoshita, Daisuke
    Kawasaki, Toshihiko
    Aihara, Yosuke
    Nakatani, Toshiya
    Kinoshita, Hiroki
    Ann, Tatsuichi
    Saito, Ko
    Yoshida, Motoyuki
    Yoshiji, Hitoshi
    ANTICANCER RESEARCH, 2022, 42 (01) : 173 - 183
  • [6] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma:A retrospective,real-world study conducted in China
    Dong-Xu Wang
    Xu Yang
    Jian-Zhen Lin
    Yi Bai
    Jun-Yu Long
    Xiao-Bo Yang
    Samuel Seery
    Hai-Tao Zhao
    World Journal of Gastroenterology, 2020, (30) : 4465 - 4478
  • [7] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
    Wang, Dong-Xu
    Yang, Xu
    Lin, Jian-Zhen
    Bai, Yi
    Long, Jun-Yu
    Yang, Xiao-Bo
    Seery, Samuel
    Zhao, Hai-Tao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (30) : 4465 - 4478
  • [8] Efficacy and safety of donafenib combined with anti-PD-1 antibodies for initially unresectable hepatocellular carcinoma (HCC): A retrospective real-world study.
    Liu, Sulai
    Zhou, Shuyi
    Song, Yinghui
    Liu, Jianming
    Guo, Chao
    Yang, Pingzhou
    Li, Ou
    Yi, Weimin
    Peng, Chuang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in China: A retrospective, real-world study.
    Yang, Xin-Rong
    Guo, De-Zhen
    Chen, Fei-Yu
    Fan, Jia
    Jian, Zhou
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Combination therapy with lenvatinib and anti-PD-1 antibodies for unresectable or advanced hepatocellular carcinoma: A real-world study.
    Sun, Hui-Chuan
    Zhu, Xiao-Dong
    Huang, Cheng
    Shen, Ying-Hao
    Ge, Ning-Ling
    Chen, Yi
    Tan, Chang-Jun
    Zhou, Jian
    Fan, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345